BSCFX | VSGAX | BSCFX / VSGAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 13 years | - |
Gain YTD | 4.403 | 3.586 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.34B | 38.1B | 11% |
Annual Yield % from dividends | 0.00 | 0.66 | - |
Returns for 1 year | 5.41 | 25.00 | 22% |
Returns for 3 years | -3.96 | 16.69 | -24% |
Returns for 5 years | 3.14 | 41.96 | 7% |
Returns for 10 years | -3.28 | 139.82 | -2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SFEPX | 20.43 | 0.19 | +0.94% |
NAA Large Core P | |||
PCBAX | 14.75 | 0.03 | +0.20% |
BlackRock Tactical Opportunities Inv A | |||
PQSCX | 24.99 | 0.02 | +0.08% |
Virtus KAR Small-Cap Value C | |||
ECASX | 28.97 | -0.02 | -0.07% |
Eaton Vance Atlanta Capital SMID-Cap C | |||
LYFCX | 12.39 | -0.10 | -0.80% |
AlphaCentric Life Sciences & Hlthcare C |